Yes it could easily goes to the $0.03 til $0.05 after a R/S. But what does it brings for us?
As long as we don't have approval, a R/S makes no sence at all. Mark my words!
Suppose the approval will be pusponed again or the FDA doesn't gives green light at all?
Before you know it, we're back in the $0.000!!!!!!!
Look at AMBS. A few months ago they announced suddenly a R/S. The Promises the CEO made has been pusponed. Opening price $ 7,50 high $12,00 low $0,26 2 weeks ago, now $ 0.82
What does that say? FDA approval needed first followed by the R/S. Never the other way around.